Antineoplastic Effects of Rosiglitazone and PPARγ Transactivation in Neuroblastoma Cells

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Geranylgeraniol Induces PPARγ Expression and Enhances the Biological Effects of a PPARγ Agonist in Adipocyte Lineage Cells

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

Targeted Enhancement of the Biological Activity of the Antineoplastic Agent, Neocarzinostatin. Studies in Murine Neuroblastoma Cells.

Journal of Clinical Investigation
Medicine
1992English

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice With Experimental Colitis

Journal of Clinical Immunology
AllergyImmunology
2007English

Antineoplastic Effects of Decitabine, an Inhibitor of DNA Promoter Methylation, in Adrenocortical Carcinoma Cells

Archives of Surgery
2010English

Endothelial Cell Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2019English

Rosiglitazone Promotes ENaC-mediated Alveolar Fluid Clearance in Acute Lung Injury Through the PPARγ/SGK1 Signaling Pathway

Cellular and Molecular Biology Letters
BiochemistryCell BiologyMolecular Biology
2019English

PPARγ Activation Induces Autophagy in Breast Cancer Cells

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2009English

Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy

HIV Clinical Trials
2012English

Genistein Inhibits Estradiol- And Environmental Endocrine Disruptor-Induced Growth Effects on Neuroblastoma Cells in Vitro

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy